Wells Fargo & Company Bone Biologics Corp Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$0.21 - $0.39 $1 - $1
5 Added 10.64%
52 $0
Q4 2022

Feb 13, 2023
BUY
$0.19 - $32.7 $4 - $850
26 Added 123.81%
47 $0
Q3 2022

Nov 14, 2022
BUY
$0.16 - $35.1 $3 - $737
21 New
21 $0

About Bone Biologics Corp

BBLG Quotes by TradingView
  • Ticker BBLG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,128,400
  • Market Cap $13M
  • Description
  • Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for sp...
More about BBLG
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email